Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma.

Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic Carcinoma. Clin Lung Cancer. 2025 May; 26(3):165-167.

View in: PubMed

subject areas

Adult
Aged
Antibodies, Monoclonal, Humanized
Camptothecin
Clinical Trials, Phase II as Topic
Female
Humans
Immunoconjugates
Male
Middle Aged
Neoplasms, Glandular and Epithelial
Thymoma
Thymus Neoplasms

authors with profiles

Marina Chiara Garassino